Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: February 02, 2026
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.
Journal: Cancer discovery
Published: December 31, 2025
Mutant KRAS peptide vaccine with dual checkpoint blockade in metastatic colorectal cancer: a phase I trial.
Journal: Nature communications
Published: December 02, 2025
Recent developments in cancer immuno-interception strategies.
Journal: Trends in molecular medicine
Published: October 31, 2025
Multi-adjuvant personalized neoantigen vaccines: Fine-tuning anti-cancer T cells.
Journal: Cell
Published: August 11, 2025
Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal.
Journal: bioRxiv : the preprint server for biology
Published: July 14, 2025
Differential cell signaling testing for cell-cell communication inference from single-cell data by dominoSignal.
Journal: Bioinformatics (Oxford, England)
Published: June 27, 2025
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.
Journal: Nature communications
Published: June 25, 2025
Mutant KRAS vaccine with dual checkpoint blockade in resected pancreatic cancer: a phase I trial.
Journal: Nature communications
Published: June 25, 2025
Emerging Systemic Therapy Considerations for Pancreatic Cancer.
Journal: Seminars in radiation oncology
Published: April 30, 2025
Last Updated: 09/26/2026